230 related articles for article (PubMed ID: 15738053)
1. An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system.
Ait-Azzouzene D; Verkoczy L; Peters J; Gavin A; Skog P; Vela JL; Nemazee D
J Exp Med; 2005 Mar; 201(5):817-28. PubMed ID: 15738053
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production.
Vela JL; Aït-Azzouzene D; Duong BH; Ota T; Nemazee D
Immunity; 2008 Feb; 28(2):161-70. PubMed ID: 18261939
[TBL] [Abstract][Full Text] [Related]
3. VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.
Palmer VL; Aziz-Seible R; Kassmeier MD; Rothermund M; Perry GA; Swanson PC
J Immunol; 2015 Aug; 195(4):1524-37. PubMed ID: 26150531
[TBL] [Abstract][Full Text] [Related]
4. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
[TBL] [Abstract][Full Text] [Related]
5. Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing.
Ota T; Ota M; Duong BH; Gavin AL; Nemazee D
J Exp Med; 2011 Mar; 208(3):617-29. PubMed ID: 21357741
[TBL] [Abstract][Full Text] [Related]
6. Positive selection of low affinity autoreactive B cells.
Kenny JJ; Lustig A; Longo DL
Curr Top Microbiol Immunol; 2000; 252():39-45. PubMed ID: 11125491
[No Abstract] [Full Text] [Related]
7. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen.
Aït-Azzouzene D; Gavin AL; Skog P; Duong B; Nemazee D
Eur J Immunol; 2006 Apr; 36(4):985-96. PubMed ID: 16511898
[TBL] [Abstract][Full Text] [Related]
8. Receptor editing and genetic variability in human autoreactive B cells.
Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
[TBL] [Abstract][Full Text] [Related]
10. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.
Prak EL; Trounstine M; Huszar D; Weigert M
J Exp Med; 1994 Nov; 180(5):1805-15. PubMed ID: 7964462
[TBL] [Abstract][Full Text] [Related]
11. Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape.
Duong BH; Ota T; Aoki-Ota M; Cooper AB; Ait-Azzouzene D; Vela JL; Gavin AL; Nemazee D
J Immunol; 2011 Dec; 187(11):5596-605. PubMed ID: 22043016
[TBL] [Abstract][Full Text] [Related]
12. Receptor editing in peripheral B cell tolerance.
Rice JS; Newman J; Wang C; Michael DJ; Diamond B
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1608-13. PubMed ID: 15659547
[TBL] [Abstract][Full Text] [Related]
13. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
14. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification.
Pelanda R; Schwers S; Sonoda E; Torres RM; Nemazee D; Rajewsky K
Immunity; 1997 Dec; 7(6):765-75. PubMed ID: 9430222
[TBL] [Abstract][Full Text] [Related]
15. Dual isotype expressing B cells [kappa(+)/lambda(+)] arise during the ontogeny of B cells in the bone marrow of normal nontransgenic mice.
Rezanka LJ; Kenny JJ; Longo DL
Cell Immunol; 2005 Nov; 238(1):38-48. PubMed ID: 16458869
[TBL] [Abstract][Full Text] [Related]
16. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
Bonami RH; Thomas JW
J Immunol; 2015 Nov; 195(10):4730-41. PubMed ID: 26432895
[TBL] [Abstract][Full Text] [Related]
17. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells.
Bynoe MS; Grimaldi CM; Diamond B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2703-8. PubMed ID: 10694576
[TBL] [Abstract][Full Text] [Related]
18. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.
Lang J; Arnold B; Hammerling G; Harris AW; Korsmeyer S; Russell D; Strasser A; Nemazee D
J Exp Med; 1997 Nov; 186(9):1513-22. PubMed ID: 9348309
[TBL] [Abstract][Full Text] [Related]
19. Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals.
Derudder E; Cadera EJ; Vahl JC; Wang J; Fox CJ; Zha S; van Loo G; Pasparakis M; Schlissel MS; Schmidt-Supprian M; Rajewsky K
Nat Immunol; 2009 Jun; 10(6):647-54. PubMed ID: 19412180
[TBL] [Abstract][Full Text] [Related]
20. A human immunoglobulin lambda locus is similarly well expressed in mice and humans.
Popov AV; Zou X; Xian J; Nicholson IC; Brüggemann M
J Exp Med; 1999 May; 189(10):1611-20. PubMed ID: 10330440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
